The influenza landscape and vaccination coverage in older adults during theSARS-Cov-2 pandemic: data from Several European Countries and Israel
While influenza and the common cold are both contagious viral respiratory tract illnesses, influenza can be a serious disease that could lead to severe complications and unfavorable outcomes due to broader consequences.
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for respiratory infection in young children.
Pacific and Atlantic sea lion mortality caused by highly pathogenic Avian Influenza A(H5N1) in South America
We describe the evolution of the outbreak of Highly Pathogenic Avian Influenza (HPAI) A(H5N1) in sea lions (Otaria flavescens) of South America.
Is eradication of influenza B viruses possible?
Influenza B virus infections account for a substantial proportion of cases of influenza annually, with a high morbidity and mortality burden, especially in children (aged 0–18 years)
In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months
Uptake of COVID-19 vaccines among pregnant individuals was hampered by safety concerns around potential risks to unborn children.
Article
News
Scientific Papers
Control of highly pathogenic avian influenza through vaccination
The stamping-out strategy has been used to control highly pathogenic avian influenza viruses in many countries.
Cryptic proteins translated from deletion-containing viral genomes dramatically expand the influenza virus proteome
Scientific Papers
Article
Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Disea
Influenza affects millions of people worldwide each year and can lead to severe complications, hospitalizations, and even death, especially among vulnerable populations such as older adults and those with chronic medical conditions.
Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The purpose of NIRSE-GAL is to evaluate the impact of the inclusion of nirsevimab in the Galician immunisation schedule on the prevention of Respiratory Syncytial Respiratory Syncytial Virus (RSV) infections in children.
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
COVID-19 vaccines have recently been updated to specifically encode or contain the spike protein of the SARS-CoV-2 XBB.1.5 subvariant.
Article
News
Scientific Papers
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
The protection of fourth dose mRNA vaccination against SARS-CoV-2 is relevant to current global policy decisions regarding ongoing booster roll-out.
